[{"id":"3de318f9-9b7c-41b4-acab-222319081456","acronym":"","url":"https://clinicaltrials.gov/study/NCT04706962","created_at":"2021-01-29T07:21:45.355Z","updated_at":"2024-07-02T16:35:27.214Z","phase":"Phase 1","brief_title":"TH1902 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT04706962","lead_sponsor":"Theratechnologies","biomarkers":" CD4","pipe":" | ","alterations":" SORT1 expression","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SORT1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sudocetaxel zendusortide (TH 1902)"],"overall_status":"Recruiting","enrollment":" Enrollment 70","initiation":"Initiation: 03/04/2021","start_date":" 03/04/2021","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-12-04"}]